{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:10:27Z","timestamp":1762114227378,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"16-17","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006303","name":"Associa\u00e7\u00e3o Fundo de Incentivo \u00e0 Pesquisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006303","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.clinbiochem.2012.06.034","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T05:07:51Z","timestamp":1342156071000},"page":"1459-1462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Higher frequency of paraoxonase gene polymorphism and cardiovascular impairment among Brazilian Fabry Disease patients"],"prefix":"10.1016","volume":"45","author":[{"given":"A.C.","family":"Barris-Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.B.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.T.","family":"Tura\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.B.","family":"Pesquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"D'Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinbiochem.2012.06.034_bb0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00439-001-0654-6","article-title":"Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm","volume":"110","author":"Ito","year":"2002","journal-title":"Hum Genet"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.06.034_bb0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2010.11.028","article-title":"Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case\u2013control studies","volume":"214","author":"Wang","year":"2011","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.clinbiochem.2012.06.034_bb0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.clinbiochem.2009.12.015","article-title":"The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease","volume":"43","author":"Mohamed","year":"2010","journal-title":"Clin Biochem"},{"issue":"5","key":"10.1016\/j.clinbiochem.2012.06.034_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"22","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"10.1016\/j.clinbiochem.2012.06.034_bb0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/qjmed\/hcq117","article-title":"Fabry disease: a review of current management strategies","volume":"103","author":"Mehta","year":"2010","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.clinbiochem.2012.06.034_bb0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","article-title":"Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells","volume":"95","author":"Shen","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.clinbiochem.2012.06.034_bb0035","doi-asserted-by":"crossref","first-page":"c289","DOI":"10.1159\/000318791","article-title":"Paraoxonase (PON1) Gene Polymorphisms in Fabry Disease: Correlation with Renal Disease","volume":"116","author":"Shemesh","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.clinbiochem.2012.06.034_bb0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1746-1596-5-65","article-title":"Reference values for lysosomal enzymes activities using dried blood spots samples \u2014 a Brazilian experience","volume":"5","author":"M\u00fcller","year":"2010","journal-title":"Diagn Pathol"},{"issue":"3","key":"10.1016\/j.clinbiochem.2012.06.034_bb0045","first-page":"598","article-title":"Molecular basis for the polymorphic forms of human serum paraoxonase\/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes","volume":"52","author":"Adkins","year":"1993","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.06.034_bb0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ng0193-73","article-title":"The molecular basis of the human serum paraoxonase activity polymorphism","volume":"3","author":"Humbert","year":"1993","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.clinbiochem.2012.06.034_bb0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.33549\/physiolres.930530","article-title":"Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant\u2013antioxidant system in Turkish patients with Type 2 diabetes mellitus","volume":"54","author":"Agachan","year":"2005","journal-title":"Physiol Res"},{"key":"10.1016\/j.clinbiochem.2012.06.034_bb0060","first-page":"522","article-title":"Paraoxonase gene Q192R & L55M polymorphisms in Indians with acute myocardial infarction & association with oxidized low density lipoprotein","volume":"131","author":"Lakshmy","year":"2010","journal-title":"Indian J Med Res"},{"author":"Preacher","key":"10.1016\/j.clinbiochem.2012.06.034_bb0065"},{"issue":"5","key":"10.1016\/j.clinbiochem.2012.06.034_bb0070","doi-asserted-by":"crossref","first-page":"e17805","DOI":"10.1371\/journal.pone.0017805","article-title":"Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis","volume":"6","author":"Gupta","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2012.06.034_bb0075","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk","volume":"299","author":"Bhattacharyya","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.clinbiochem.2012.06.034_bb0080","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1373\/clinchem.2007.099044","article-title":"Factors associated with paraoxonase genotypes and activity in a diverse, young, healthy population: the Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"54","author":"Thyagarajan","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2012.06.034_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0404.2006.00765.x","article-title":"PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals","volume":"116","author":"Schiavon","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clinbiochem.2012.06.034_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2007.08.010","article-title":"Paraoxonase\/arylesterase ratio, PON1 192Q\/R polymorphism and PON1status are associated with increased risk of ischemic stroke","volume":"41","author":"Can Demird\u00f6\u011fen","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2012.06.034_bb0095","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/art.21889","article-title":"Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus","volume":"54","author":"Tripi","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012003384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012003384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:08:06Z","timestamp":1762114086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012003384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":19,"journal-issue":{"issue":"16-17","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0009912012003384"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.06.034","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher frequency of paraoxonase gene polymorphism and cardiovascular impairment among Brazilian Fabry Disease patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}